The Current Ratio as of December 2025 (TTM) for Cabio Biotech (Wuhan) Co., Ltd. (688089.SS) is 5.79

According to Cabio Biotech (Wuhan) Co., Ltd.’s latest financial reports and current stock price. The company's current Current Ratio is 5.79. This represents a change of -5.29% compared to the average of 6.12 of the last 4 quarters.

Cabio Biotech (Wuhan) Co., Ltd. (688089.SS) Historical Current Ratio (quarterly & annually)

How has 688089.SS Current Ratio performed in the past?

The mean historical Current Ratio of Cabio Biotech (Wuhan) Co., Ltd. over the last ten years is 10.45. The current 5.79 Current Ratio has changed 5.44% with respect to the historical average. Over the past ten years (40 quarters), 688089.SS's Current Ratio was at its highest in in the March 2020 quarter at 30.00. The Current Ratio was at its lowest in in the March 2019 quarter at 0.

Cabio Biotech (Wuhan) Co., Ltd. (688089.SS) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Cabio Biotech (Wuhan) Co., Ltd. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Cabio Biotech (Wuhan) Co., Ltd. (688089.SS) Average Current Ratio

How has 688089.SS Current Ratio performed in the past?

The current Current Ratio of Cabio Biotech (Wuhan) Co., Ltd. (688089.SS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Cabio Biotech (Wuhan) Co., Ltd. (688089.SS) Current Ratio vs. Peers

How is 688089.SS’s Current Ratio compared to its peers?

Cabio Biotech (Wuhan) Co., Ltd.’s Current Ratio is greater than Baolingbao Biology Co.,Ltd. (1.83), greater than Zhejiang Shouxiangu Pharmaceutical Co., Ltd. (3.82), greater than Qingdao Vland Biotech Inc. (1.08), greater than Hvsen Biotechnology Co., Ltd. (1.70), less than Shanghai ZJ Bio-Tech Co., Ltd. (23.06), less than Shanghai Hile Bio-Technology Co., Ltd. (7.63), greater than Zhejiang Wecome Pharmaceutical Company Limited (2.34), greater than Hainan Huluwa Pharmaceutical Group Co., Ltd. (0.82), greater than Guanhao Biotech Co.,Ltd. (1.97), less than Yantai Zhenghai Biotechnology Co., Ltd. (8.89),

Build a custom stock screener for Cabio Biotech (Wuhan) Co., Ltd. (688089.SS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cabio Biotech (Wuhan) Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Cabio Biotech (Wuhan) Co., Ltd. (688089.SS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Cabio Biotech (Wuhan) Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.